南方精工(002553.SZ):控股股東史建偉擬將所持5.00%股份轉讓給嘉鴻寶光1號基金
格隆匯5月17日丨南方精工(002553.SZ)公佈,2023年5月17日,江蘇南方精工股份有限公司控股股東史建偉先生與浙江嘉鴻資產管理有限公司(簡稱“嘉鴻資產”)簽署了《股份轉讓協議》,史建偉先生擬將其持有的部分公司無限售流通股合計17,400,000股(佔公司目前總股本的5.00%)轉讓給嘉鴻資產管理的嘉鴻寶光1號私募證券投資基金(簡稱“嘉鴻寶光1號基金”)。
本次協議轉讓前,嘉鴻寶光1號基金未持有公司股份;本次協議轉讓完成後,嘉鴻寶光1號基金持有公司股份17,400,000股,佔公司目前總股本的5.00%,成為公司持股5%以上(含本數)的股東。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.